| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.91B | +8.5% | +77.4% |
| Cost of Revenue | $4.72B | +7.1% | +76.3% |
| Gross Profit | $1.19B | +14.5% | +82.0% |
| R&D Expense | $44.0M | +15.8% | +63.0% |
| SG&A Expense | $488.0M | +10.9% | +61.1% |
| Operating Income | $461.0M | +39.3% | +47.3% |
| Pre-tax Income | $310.0M | +74.2% | +30.8% |
| Income Tax | $32.0M | +966.7% | -20.0% |
| Net Income | $278.0M | +57.1% | +41.8% |
| EPS (Basic) | $0.60 | +57.9% | +341.2% |
| EPS (Diluted) | $0.60 | +57.9% | +341.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.59B | +50.1% | -22.4% |
| Accounts Receivable | $3.51B | +11.1% | +78.4% |
| Current Assets | $9.83B | +14.8% | +46.6% |
| Total Assets | $37.58B | +1.4% | +108.3% |
| Current Liabilities | $6.81B | +3.6% | +72.9% |
| Long-term Debt | $15.20B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $556.0M | — | — |
| Investing Cash Flow | -$596.0M | — | — |
| Financing Cash Flow | $819.0M | — | — |
| +76.0% |
| Total Liabilities | $25.92B | +2.1% | +82.8% |
| Stockholders' Equity | $11.65B | +0.1% | +202.5% |